CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net sales	$ 978	$ 969
Cost of products sold	459	448
Gross profit	519	521
Selling, general, and administrative expenses	416	376
Research and development expenses	46	45
Restructuring and other costs	59	3
Operating (loss) income	(2)	97
Other income and expenses:
Interest expense, net	19	12
Other expense (income), net	7	(2)
(Loss) income before income taxes	(28)	87
(Benefit) provision for income taxes	(5)	18
Net (loss) income	(23)	69
Less: Net loss attributable to noncontrolling interest	(4)	0
Net (loss) income attributable to Dentsply Sirona	$ (19)	$ 69
Net (loss) income per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ (0.09)	$ 0.32
Diluted (in dollars per share)	$ (0.09)	$ 0.32
Weighted average common shares outstanding:
Basic (in shares)	214.5	217.0
Diluted (in shares)	214.5	217.8